Vascular dysfunction in hyperglycemia: is protein kinase C the culprit?
Gutterman
David D
DD
D001783:Blood Flow Velocity / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005542:Forearm / Q000098:blood supply; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology*; D007211:Indoles / Q000097:blood / Q000494:pharmacology*; D008301:Maleimides / Q000097:blood / Q000494:pharmacology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D014664:Vasodilation / Q000187:drug effects*
D004791:Enzyme Inhibitors; D007211:Indoles; D008301:Maleimides; C099154:ruboxistaurin; D011493:Protein Kinase C